Golden State Wealth Management, LLC Arcutis Biotherapeutics, Inc. Transaction History
Golden State Wealth Management, LLC
- $673 Billion
- Q1 2025
A detailed history of Golden State Wealth Management, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 59 shares of ARQT stock, worth $879. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 118
50.0%
Holding current value
$879
Previous $1,000
92200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARQT
# of Institutions
226Shares Held
129MCall Options Held
2.02MPut Options Held
202K-
Jennison Associates LLC12.3MShares$184 Million0.11% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.4MShares$170 Million6.61% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$164 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$131 Million7.34% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$129 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $897M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...